A recent study showed that diosmetin, an O-methylated flavanone targets ERβ and ERβ expression conferred cell sensitivity, as patient-derived AML cells with high levels of ERβ were sensitive, whereas cells with low ERβ were less sensitive to diosmetin [45]. Here, ESR2 is linked to acute myeloid leukemia.